HKG: 2367

Company Deals

Giant Biogene Set for IPO on Hong Kong Stock Exchange to Raise Funds for Expansion

Fineline Cube Oct 25, 2022

China-based medical aesthetics company Giant Biogene Holding Co., Ltd (HKG: 2367) has announced plans to...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod